K. Klette

发表

Validation of the only commercially available immunoassay for synthetic cathinones in urine: Randox Drugs of Abuse V Biochip Array Technology.

Kayla N. Ellefsen, Sébastien Anizan, M. Castaneto, 2014, Drug testing and analysis.

Comparison of EMIT II, CEDIA, and DPC RIA assays for the detection of lysergic acid diethylamide in forensic urine samples.

K. Klette, P. Stout, Russell F Wiegand, 2002, Journal of analytical toxicology.

The quantitation of 2-oxo-3-hydroxy lysergic acid diethylamide (O-H-LSD) in human urine specimens, a metabolite of LSD: comparative analysis using liquid chromatography-selected ion monitoring mass spectrometry and liquid chromatography-ion trap mass spectrometry.

K. Klette, G. Poch, C. Anderson, 2000, Journal of analytical toxicology.

Method validation of the biochip array technology for synthetic cannabinoids detection in urine.

Kayla N. Ellefsen, Sébastien Anizan, M. Castaneto, 2014, Bioanalysis.

σ receptor-mediated neuroprotection against glutamate toxicity in primary rat neuronal cultures

F. Tortella, K. Klette, M. DeCoster, 1995, Brain Research.

Detection of metabolites of lysergic acid diethylamide (LSD) in human urine specimens: 2-oxo-3-hydroxy-LSD, a prevalent metabolite of LSD.

K. Klette, L. McWhorter, G. Poch, 1999, Journal of chromatography. B, Biomedical sciences and applications.

Complete automation of solid-phase extraction with subsequent liquid chromatography-tandem mass spectrometry for the quantification of benzoylecgonine, m-hydroxybenzoylecgonine, p-hydroxybenzoylecgonine, and norbenzoylecgonine in urine--application to a high-throughput urine analysis laboratory.

K. Klette, Louis J Reda, Paul P Robandt, 2008, Journal of analytical toxicology.

Solid-phase extraction and GC-MS analysis of THC-COOH method optimized for a high-throughput forensic drug-testing laboratory.

K. Klette, P. Stout, C. K. Horn, 2001, Journal of analytical toxicology.

Urinary Pharmacokinetics of 11-Nor-9-carboxy-Δ9-tetrahydrocannabinol after Controlled Oral Δ9-Tetrahydrocannabinol Administration

Richard A. Gustafson, K. Klette, M. Huestis, 2004 .

Urinary cannabinoid detection times after controlled oral administration of delta9-tetrahydrocannabinol to humans.

Richard A. Gustafson, K. Klette, M. Huestis, 2003, Clinical chemistry.

Role of calcium in sigma-mediated neuroprotection in rat primary cortical neurons

F. Tortella, K. Klette, M. DeCoster, 1995, Brain Research.

Dextromethorphan analogs are neuroprotective in vitro and block glutamate-induced excitotoxic calcium signals in neurons

F. Tortella, K. Klette, M. DeCoster, 1995, Neuroscience Letters.

Evaluation of a homogenous enzyme immunoassay for the detection of synthetic cannabinoids in urine.

T. M. Martin, K. Klette, M. Huestis, 2014, Forensic science international.

Phospholipase A2-induced neurotoxicity in vitro and in vivo in rats

F. Tortella, R. Smallridge, J. Dave, 1995, Brain Research.

Automated solid-phase extraction-liquid chromatography-tandem mass spectrometry analysis of 6-acetylmorphine in human urine specimens: application for a high-throughput urine analysis laboratory.

K. Klette, P. V. Robandt, H. Bui, 2010, Journal of analytical toxicology.

Rapid quantification of urinary oxycodone and oxymorphone using fast gas chromatography-mass spectrometry.

K. Klette, M. Jamerson, E. Welsh, 2007, Journal of analytical toxicology.

Rapid simultaneous determination of amphetamine, methamphetamine, 3,4-methylenedioxyamphetamine, 3,4-methylenedioxymethamphetamine, and 3,4-methylenedioxyethylamphetamine in urine by solid-phase extraction and GC-MS: a method optimized for high-volume laboratories.

K. Klette, P. Stout, C. K. Horn, 2002, Journal of analytical toxicology.

LC-mS analysis of human urine specimens for 2-oxo-3-hydroxy LSD: method validation for potential interferants and stability study of 2-oxo-3-hydroxy LSD under various storage conditions.

K. Klette, P. Stout, C. Anderson, 2002, Journal of analytical toxicology.

Urine Mescaline Screening With a Biochip Array Immunoassay and Quantification by Gas Chromatography–Mass Spectrometry

M. Castaneto, T. M. Martin, K. Klette, 2015, Therapeutic drug monitoring.

Urine pH, container composition, and exposure time influence adsorptive loss of 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid.

K. Klette, M. Jamerson, J. J. McCue, 2005, Journal of analytical toxicology.

Urine benzodiazepine screening using Roche Online KIMS immunoassay with beta-glucuronidase hydrolysis and confirmation by gas chromatography- mass spectrometry.

K. Klette, P. Stout, Russell F Wiegand, 2005, Journal of analytical toxicology.

Comparison of the Microgenics CEDIA heroin metabolite (6-AM) and the Roche Abuscreen ONLINE opiate immunoassays for the detection of heroin use in forensic urine samples.

K. Klette, Russell F Wiegand, A. Jacobs, 2004, Journal of analytical toxicology.

Evaluation of ephedrine, pseudoephedrine and phenylpropanolamine concentrations in human urine samples and a comparison of the specificity of DRI amphetamines and Abuscreen online (KIMS) amphetamines screening immunoassays.

K. Klette, P. Stout, C. K. Horn, 2004, Journal of forensic sciences.

LC-MS Analysis of 2-Oxo-3-Hydroxy LSD from Urine Using a Speedisk | Positive-Pressure Processor with Cerex

K. Klette, C. K. Horn, Peter R. Stoul, 2012 .

LC-MS analysis of 2-oxo-3-hydroxy LSD from urine using a Speedisk positive-pressure processor with Cerex PolyChrom CLIN II columns.

K. Klette, P. Stout, C. K. Horn, 2003, Journal of analytical toxicology.

Metabolism of lysergic acid diethylamide (LSD) to 2-oxo-3-hydroxy LSD (O-H-LSD) in human liver microsomes and cryopreserved human hepatocytes.

K. Klette, A. Nimrod, M. Elsohly, 2000, Journal of analytical toxicology.

Prescription drug misuse among U.S. active duty military personnel: a secondary analysis of the 2008 DoD survey of health related behaviors.

K. Klette, M. Kloc, Lorraine A Babeu, 2013, Military medicine.

Occupational exposure to methamphetamine in workers preparing training AIDS for drug detection dogs.

K. Klette, J. Given, P. Stout, 2006, Journal of analytical toxicology.

Evaluation of a solid-phase extraction method for benzoylecgonine urine analysis in a high-throughput forensic urine drug-testing laboratory.

K. Klette, P. Stout, J. M. Gehlhausen, 2002, Journal of analytical toxicology.

Quantitative urine confirmatory testing for synthetic cannabinoids in randomly collected urine specimens.

M. Castaneto, T. M. Martin, K. Klette, 2015, Drug testing and analysis.

Performance characteristics of an ELISA screening assay for urinary synthetic cannabinoids.

M. Castaneto, T. M. Martin, K. Klette, 2015, Drug testing and analysis.

Urinary prevalence, metabolite detection rates, temporal patterns and evaluation of suitable LC-MS/MS targets to document synthetic cannabinoid intake in US military urine specimens

M. Castaneto, Nathalie A. Desrosiers, T. M. Martin, 2015, Clinical chemistry and laboratory medicine.

Neuroprotective sigma ligands attenuate NMDA and trans-ACPD-induced calcium signaling in rat primary neurons

F. Tortella, K. Klette, M. DeCoster, 1997, Brain Research.

Use and abuse of prescribed opioids, central nervous system depressants, and stimulants among U.S. active duty military personnel in FY 2010.

K. Klette, Bill Luckey, D. Jeffery, 2014, Military medicine.

Biochip array technology immunoassay performance and quantitative confirmation of designer piperazines for urine workplace drug testing

M. Castaneto, K. Klette, M. Huestis, 2015, Analytical and Bioanalytical Chemistry.

K. Klette, M. Jamerson, C. Morris-Kukoski, 2005, Journal of analytical toxicology.

Comparison and evaluation of DRI methamphetamine, DRI ecstasy, Abuscreen ONLINE amphetamine, and a modified Abuscreen ONLINE amphetamine screening immunoassays for the detection of amphetamine (AMP), methamphetamine (MTH), 3,4-methylenedioxyamphetamine (MDA), and 3,4-methylenedioxymethamphetamine (M

K. Klette, P. Stout, Russell F Wiegand, 2003, Journal of analytical toxicology.

Automated solid-phase extraction-liquid chromatography-tandem mass spectrometry analysis of 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in human urine specimens: application to a high-throughput urine analysis laboratory.

K. Klette, M. Sibum, P. V. Robandt, 2009, Journal of analytical toxicology.

Rapid quantification of urinary 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid using fast gas chromatography-mass spectrometry.

K. Klette, M. Jamerson, R. Welton, 2005, Journal of analytical toxicology.

Urinary pharmacokinetics of 11-nor-9-carboxy-delta9-tetrahydrocannabinol after controlled oral delta9-tetrahydrocannabinol administration.

Richard A. Gustafson, K. Klette, M. Huestis, 2004, Journal of analytical toxicology.

Simultaneous GC-MS analysis of meta- and para-hydroxybenzoylecgonine and norbenzoylecgonine: a secondary method to corroborate cocaine ingestion using nonhydrolytic metabolites.

K. Klette, G. Poch, R. Czarny, 2000, Journal of analytical toxicology.